Roche’s cobas Babesia Blood Test Receives the US FDA’s Approval for Donor Screening

 Roche’s cobas Babesia Blood Test Receives the US FDA’s Approval for Donor Screening

Roche’s cobas Babesia Blood Test Receives the US FDA’s Approval for Donor Screening

Shots:

  • The US FDA has granted approval for Roche’s cobas Babesia Test on the cobas 6800/8800 Systems for individual blood donation testing following May 2019 FDA updated industry guidance recommending screening and testing for Babesia, thus reducing the risk of transmitting the parasite via transfusion
  • The approval follows the launch of the cobas Zika test, leading to an expansion of Roche’s menu of tests for the cobas 6800/8800 Systems for use in donor screening laboratories in the US
  • The cobas Babesia test detects parasite living in RBCs, enable to detect 4 species of Babesia and employs the new whole blood collection tube, simplifying preparation by consolidating steps within the tube itself providing an efficient solution for testing laboratories

Click here to­ read full press release/ article | Ref: Roche | Image: Cash

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post